title: Unfavourable prognostic significance of S100P expression in ovarian cancers.
authors.forename: P
authors.initials: P
authors.lastname: Surowiak
authors.forename: A
authors.initials: A
authors.lastname: Maciejczyk
authors.forename: V
authors.initials: V
authors.lastname: Materna
authors.forename: M
authors.initials: M
authors.lastname: Drag-Zalesińska
authors.forename: A
authors.initials: A
authors.lastname: Wojnar
authors.forename: M
authors.initials: M
authors.lastname: Pudelko
authors.forename: W
authors.initials: W
authors.lastname: Kedzia
authors.forename: M
authors.initials: M
authors.lastname: Spaczyński
authors.forename: M
authors.initials: M
authors.lastname: Dietel
authors.forename: M
authors.initials: M
authors.lastname: Zabel
authors.forename: H
authors.initials: H
authors.lastname: Lage
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D016022:Case-Control Studies; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D053208:Kaplan-Meier Estimate; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents; D002135:Calcium-Binding Proteins; D009363:Neoplasm Proteins; C103003:S100P protein, human